If promising results on a skin cancer vaccine from Moderna and Merck lead to a new launch, the Covid-19 era darling's stock ...

Moderna Inc (NASDAQ:MRNA) shares are trading higher on Wednesday on continued momentum after the company's Tuesday update ...

US stocks spiked on Wednesday after President Trump announced the US and NATO "formed the framework of a future deal" on ...

Merck & Co., Inc. (NYSE:MRK) is included in our list of the 10 Goldman Sachs undervalued stocks to invest in. As of January ...

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...

​Guardant Health, Inc. (NASDAQ:GH) is one of the Best Russell 2000 Stocks to Buy Right Now. Wall Street has a positive ...

In the Phase 2b trials, this combination therapy achieved a 49% decrease in the risk of recurrence or death relative to ...

Explore SPYV: a large-cap value S&P 500 ETF with diversified sectors, a 16% P/E discount, and lower volatility. Read the full ...

Liquidia fit this approach well. Their launch may go down as one of the most successful drug launches ever. They have already taken 25% market share and are effectively expanding the market. Amazingly ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 8.8% in the afternoon session after the company, in partnership with Merck, announced positive results from a five-year follow-up study of ...

India's largest drugmaker, Sun Pharma, is considering a major acquisition. The company is evaluating the purchase of US-based ...

Sun Pharma is weighing the acquisition of US-based Organon in a deal valued at about $10 billion, a move that would ...